Appropriate Use of Inpatient Erythropoiesis Stimulating Agents
Background: Anemia is a significant global public health issue, and it is associated with lethargy, weakness, tiredness, and shortness of breath. Erythropoietin stimulating agents (ESAs) are recombinant / synthetic erythropoietin and can increase hemoglobin (Hb) levels. There are increased risks of...
Saved in:
Main Authors: | Chenghao Cui, Timothy Nguyen, Mohammad Rattu |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Minnesota Libraries Publishing
2024-11-01
|
Series: | INNOVATIONS in Pharmacy |
Subjects: | |
Online Access: | https://pubs.lib.umn.edu/index.php/innovations/article/view/6284 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Renal anemia and hyporesponsiveness to ESA for preservation of residual kidney function in patients undergoing peritoneal dialysis
by: Takahiro Imaizumi, et al.
Published: (2025-01-01) -
Parameter estimation in a structured erythropoiesis model
by: Azmy S. Ackleh, et al.
Published: (2008-09-01) -
Defective Slc7a7 transport reduces erythropoietin compromising erythropoiesis
by: Judith Giroud-Gerbetant, et al.
Published: (2025-01-01) -
Harnessing the power of proteins in modulation of miRNAs for targeting Iron deficiency Anemia: Opinion for future implications and strategies
by: Ray Wagiu Basrowi, et al.
Published: (2025-01-01) -
The influencing factors of the erythropoietin resistance index and its association with all-cause mortality in maintenance hemodialysis patients
by: Xinju Zhao, et al.
Published: (2024-12-01)